Skip to main content

Microba Life Sciences Health Care

$0.300 -0.015 (-4.76%)

High

$0.31

Low

$0.30

Trades

7

Turnover

$48,780

Volume

160,000
30 June 2023 at 4:10pm
Register to track MAP and receive email alerts.
MAP Announcements on Price Chart

Latest Announcements

Headline Date
Notification of cessation of securities - MAP 30 June 2023 at 5:35pm
Microba Commences Phase I Clinical Trial for IBD Therapeutic 28 June 2023 at 9:25am
MRFF Grant Awarded to QUT, In Collaboration With Microba 27 June 2023 at 11:45am
Notification of cessation of securities - MAP 16 June 2023 at 4:50pm
Microba receives two AusIndustry Advanced Overseas Findings 14 June 2023 at 2:30pm
Appendix 3Z - Final Director's Interest Notice 14 June 2023 at 9:25am
Director Resignation 6 June 2023 at 1:00pm
Application for quotation of securities - MAP 29 May 2023 at 12:20pm
Cleansing Notice 29 May 2023 at 11:55am
Change in substantial holding - Tiga Trading Pty Ltd 12 May 2023 at 5:10pm
Change in substantial holding from TEK 12 May 2023 at 5:10pm
Cleansing Notice 3 May 2023 at 11:45am
Application for quotation of securities - MAP 3 May 2023 at 11:45am
Q3 FY23 Quarterly Investor Presentation 20 April 2023 at 9:35am
Q3 FY23 Quarterly Activities Report & Appendix 4C 20 April 2023 at 9:35am
Details of Q3 FY23 Quarterly Report, Appendix 4C & Webinar 19 April 2023 at 12:15pm
Cleansing Notice 14 April 2023 at 4:45pm
Application for quotation of securities - MAP 14 April 2023 at 4:45pm
SYNLAB Contracts Signed in Poland, Hungary, Romania, Croatia 13 April 2023 at 9:40am
Microba Receives Ethics Approval for Phase 1 Clinical Trial 29 March 2023 at 3:00pm
Release of Securities from Voluntary Escrow 28 March 2023 at 9:35am
NWR Virtual Healthcare Conference Presentation 21 March 2023 at 10:10am
Microba to present at NWR Virtual Investor Conference 16 March 2023 at 9:30am
SYNLAB Agreements Signed in Turkiye and Czech Republic 2 March 2023 at 9:30am
Microba Launches Next Generation Healthcare Testing 28 February 2023 at 9:25am
H1 FY23 Interim Report 23 February 2023 at 9:35am
ShareCafe Small Cap Hidden Gems Presentation 9 February 2023 at 9:20am
US Distribution Agreement Signed with Luminary Health 7 February 2023 at 9:30am
Notification regarding unquoted securities - MAP 2 February 2023 at 1:30pm
Results of General Meeting 1 February 2023 at 1:20pm
Positive first animal data for Cancer Program 1 February 2023 at 9:50am
Q2 FY23 Quarterly Investor Presentation 31 January 2023 at 9:25am
Q2 FY23 Quarterly Activities Report & Appendix 4C 30 January 2023 at 9:30am
Details of Q2 FY23 Investor Webinar 30 January 2023 at 9:05am
Letter to Shareholders, Notice of Meeting & Proxy Form 20 December 2022 at 4:25pm
SYNLAB Agreements Signed in Italy and Portugal 8 December 2022 at 9:25am
Change in substantial holding - Tiga Trading Pty Ltd 5 December 2022 at 5:35pm
Change in substantial holding from TEK 5 December 2022 at 5:30pm
Ceasing to be a substantial holder 2 December 2022 at 7:40pm
Change in substantial holding 2 December 2022 at 7:40pm
Change in substantial holding 2 December 2022 at 7:35pm
Change in substantial holding 2 December 2022 at 7:35pm
Change in substantial holding 2 December 2022 at 7:35pm
Change in substantial holding 2 December 2022 at 3:20pm
Becoming a substantial holder from SHL 2 December 2022 at 9:55am
Cleansing Notice 1 December 2022 at 3:05pm
Application for quotation of securities - MAP 1 December 2022 at 12:10pm
SHL: STRATEGIC STAKE AND COMMERCIAL PARTNERSHIP WITH MICROBA 29 November 2022 at 9:55am
Proposed issue of securities - MAP 29 November 2022 at 9:45am
Proposed issue of securities - MAP 29 November 2022 at 9:45am
Register to track MAP and receive email alerts.